Diagnostics News and Research

RSS

Menarini Group signs licensing deal with Insilico for promising cancer treatment

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to cancer patients, and Insilico Medicine ("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, today announced that the companies have entered into an exclusive licensing agreement granting Stemline the global rights to develop and commercialize a preclinical small molecule targeting high unmet needs in oncology.

10 Jan 2025

Eating more fiber supports growth of good bacteria and protects against gut infections

The group of bacteria called Enterobacteriaceae, including Klebsiella pneumoniae, Shigella, E.coli and others, is present at low levels as part of a healthy human gut microbiome.

10 Jan 2025

Sex-specific mitochondrial marker deficiencies linked to early cognitive dysfunction in Alzheimer’s disease

Research reveals sex-specific free-carnitine deficiency in women with cognitive impairment, linking mitochondrial metabolism to Alzheimer's disease progression.

10 Jan 2025

World’s largest proteomics study launched by UK Biobank

UK Biobank has today announced the launch of the world's most comprehensive study of the proteins circulating in our bodies, which will transform the study of diseases and their treatments.

9 Jan 2025

Geneoscopy closes $105 M in Series C funding round to power next-generation of gastrointestinal diagnostic tests

Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the closing of a Series C funding round raising $105 million.

9 Jan 2025

Stanford researchers develop AI model to enhance cancer prognosis predictions

The melding of visual information (microscopic and X-ray images, CT and MRI scans, for example) with text (exam notes, communications between physicians of varying specialties) is a key component of cancer care.

8 Jan 2025

Early detection of breast cancer proven cost-effective for Canada's health care system

Cancer screening is key to saving patients' lives since an earlier stage diagnosis improves survival rates, decreases morbidity, and leads to less intensive treatments.

7 Jan 2025

Hidden culprit: Human metapneumovirus identified in severe adult pneumonia case

Severe pneumonia caused by human metapneumovirus in an immunocompetent adult highlights diagnostic challenges and underscores the need for rapid molecular diagnostics to improve outcomes.

6 Jan 2025

AI-based SCORPIO tool offers better cancer immunotherapy predictions

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of immunotherapy - using only routine blood tests and clinical data.

6 Jan 2025

Australian study warns of growing drug resistance in canine hookworms

Canine hookworms are becoming increasingly resistant to drugs across Australia, according to new research.

6 Jan 2025

AI diagnostics offer hope for Sudan's collapsing health system

Sudanese health authorities are turning to AI to strengthen health systems after dozens of doctors were killed in the country's almost two-year long civil war, according to a senior official.

6 Jan 2025

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Under Rhiannon White's leadership, Clue is transforming menstrual health tracking into a powerful tool for research and improved reproductive health outcomes.

3 Jan 2025

A new blood test for endometriosis

Australian researchers develop novel test to diagnose debilitating condition affecting one in nine Australian women and girls.

3 Jan 2025

New nanopore-based tool enables single molecule disease detection

UC Riverside scientists have developed a nanopore-based tool that could help diagnose illnesses much faster and with greater precision than current tests allow, by capturing signals from individual molecules.

2 Jan 2025

AI-based models can outperform human experts at identifying ovarian cancer

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images.

2 Jan 2025

Kewaunee & NuAire: Market Leaders Join Forces to Revolutionize the Industry

NuAire joins Kewaunee Scientific Corporation, enhancing laboratory solutions with a comprehensive portfolio of incubators, fume hoods, and biosafety cabinets.

From NuAire 30 Dec 2024

AMF at SLAS 2025: Precision microfluidics in San Diego

AMF is excited to participate in the SLAS 2025 International Conference & Exhibition, taking place from January 25-29, 2025 at the San Diego Convention Center. This renowned event will bring together professionals from across the life sciences, biotech, and automation industries to showcase the latest innovations and technologies.

From Advanced Microfluidics SA 24 Dec 2024

Assessing the impact of gozetotide in PSMA-positive prostate cancer

Gozetotide is a drug for diagnostic application in adults with prostate cancer. It is currently the only diagnostic agent that recognizes PSMA-positive prostate cancer and can therefore identify patients for whom PSMA-targeted therapy with (177Lu)lutetium vipivotide tetraxetan ("Lutetium-177" for short) is an option.

20 Dec 2024

New review discusses the expanding horizons of AI in medical sciences

In recent years, artificial intelligence (AI) has grown remarkably, fueled by innovative foundation models (FMs) such as GPT-n series by OpenAI, and derived large language models (LLMs) like Chat generative pre-trained transformer, popularly known as ChatGPT.

20 Dec 2024

AI model enhances early detection of skin cancer with high accuracy

Skin cancer remains the most common form of cancer worldwide, often presenting as benign skin conditions that are difficult to differentiate, even for experienced dermatologists.

20 Dec 2024